Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
VIGL Vigil Neuroscience Inc
- Stocks
- Healthcare
- NASDAQ: VIGL
Price (delayed)
$7.9
Market cap
$368.71M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$2.05
Enterprise value
$328.85M
Vigil Neuroscience, Inc., a microglia-focused company, engages in the development of disease-modifying therapeutics for patients, caregivers, and families affected by rare and common neurodegenerative diseases. Its lead product candidate is
Highlights
The debt has decreased by 7% YoY
Vigil Neuroscience's EPS has increased by 3.3% YoY
The quick ratio has dropped by 76% year-on-year
Vigil Neuroscience's equity has decreased by 37% YoY and by 9% from the previous quarter
Key stats
What are the main financial stats of VIGL
Market
Valuations
Earnings
Shares outstanding
46.67M
Market cap
$368.71M
Enterprise value
$328.85M
Price to earnings (P/E)
N/A
Price to book (P/B)
5.66
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
Gross profit
$0
Operating income
-$91.74M
Net income
-$86.73M
EBIT
-$86.73M
EBITDA
-$84.84M
Free cash flow
-$53.53M
Per share
Balance sheet
Liquidity
EPS
-$2.05
EPS diluted
-$2.05
Free cash flow per share
-$1.16
Book value per share
$1.4
Revenue per share
$0
TBVPS
$2.33
Total assets
$107.15M
Total liabilities
$42.03M
Debt
$12.69M
Equity
$65.12M
Working capital
$59.75M
Debt to equity
0.19
Current ratio
2.97
Quick ratio
2.9
Net debt/EBITDA
0.47
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-74.7%
Return on equity
-111.7%
Return on invested capital
-148%
Return on capital employed
-113%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
VIGL stock price
How has the Vigil Neuroscience stock price performed over time
Intraday
-0.13%
1 week
0.13%
1 month
187.27%
1 year
214.74%
YTD
364.71%
QTD
343.82%
Financial performance
How have Vigil Neuroscience's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$91.74M
Net income
-$86.73M
Gross margin
N/A
Net margin
N/A
The company's net income fell by 4.8% YoY and by 2.9% QoQ
The operating income has contracted by 2.5% YoY and by 2.3% from the previous quarter
Price vs fundamentals
How does VIGL's price correlate with its fundamentals
Growth
What is Vigil Neuroscience's growth rate over time
Valuation
What is Vigil Neuroscience stock price valuation
P/E
N/A
P/B
5.66
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Vigil Neuroscience's EPS has increased by 3.3% YoY
Vigil Neuroscience's equity has decreased by 37% YoY and by 9% from the previous quarter
Efficiency
How efficient is Vigil Neuroscience business performance
The ROIC has plunged by 76% YoY and by 21% from the previous quarter
The return on equity has dropped by 72% year-on-year and by 16% since the previous quarter
The return on assets has declined by 36% year-on-year and by 7% since the previous quarter
Dividends
What is VIGL's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for VIGL.
Financial health
How did Vigil Neuroscience financials performed over time
The total assets is 155% greater than the total liabilities
VIGL's total liabilities has surged by 97% year-on-year but it is down by 9% since the previous quarter
The company's current ratio has shrunk by 76% YoY
The debt is 81% less than the equity
Vigil Neuroscience's debt to equity has increased by 46% YoY and by 6% from the previous quarter
Vigil Neuroscience's equity has decreased by 37% YoY and by 9% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.